BioNet News 13 Feb 2023 Produire des médicaments et des vaccins en Occitanie : un ambitieux projet porté à Toulouse Et si on produisait bientôt des médicaments et des vaccins en Occitanie ? Le CHU de Toulouse et ses partenaires… Supachai
Biotech News 07 Feb 2023 The next generation of coronavirus vaccines: a graphical guide New technologies might provide more potent or broader immunity — but will have to fight for market share. Vaccines against… Supachai
BioNet News, Press Releases 17 Dec 2022 Pharmaniaga and BioNet Sign Research Collaboration Agreement for Children’s Hexavalent Vaccine KUALA LUMPUR, 13 DECEMBER 2022 – Pharmaniaga LifeScience Sdn Bhd (PLS), a wholly-owned subsidiary of Malaysia's leading pharmaceutical company, Pharmaniaga… Supachai
BioNet News, Press Releases 08 Dec 2022 INFECTIOUS AND EMERGING DISEASES: A BIOCLUSTER PROJECT IN OCCITANIA Toulouse, Lyon and Bangkok, 8th December 2022 - Within the framework of the "BIOCLUSTER" Call for Expressions of Interest of… Supachai
BioNet News, Press Releases 28 Nov 2022 BioNet CEO discussed with French President Emmanuel Macron during APEC in Bangkok. Bangkok, 28th November 2022 - French President Emmanuel Macron took the opportunity of his attendance to the Thailand-hosted Asia Pacific… Supachai
BioNet News, Covid-19, Press Releases 16 Nov 2022 Phase 2 trial of ChulaCov19 BNA159 mRNA Vaccine to start in Australia ChulaCov19 BNA159 is a COVID-19 mRNA vaccine developed by Chulalongkorn University and produced by BioNet ChulaCov19 mRNA vaccine was found… Supachai
BioNet News, Pertussis 17 Jun 2022 Etude Pertagen® 2xÉTUDE SUR PERTAGEN®, UN NOUVEAU VACCIN CONTRE LA COQUELUCHE Statut En cours de recrutement. La coqueluche circule largement chez les jeunes, qui jouent un rôle de réservoir et transmettent… Supachai
Biotech News 05 May 2022 Thailand’s first Covid-19 vaccine waits for approval from local FDA Better late than never. Thailand’s first Covid-19 vaccine, ChulaCov19, has shown impressive results in the first and second rounds of… Supachai
Biotech News 07 Apr 2022 New crop of COVID-19 mRNA vaccines could be easier to store, cheaper to use If approved, they could bring the pandemic’s star vaccine technology to more of the world The two COVID-19 vaccines based… Supachai
BioNet News, Covid-19, Press Releases 21 Mar 2022 Technovalia, Sypharma and BioNet announce the establishment of Genetis, the first Australian Vaccine Development and Manufacturing Hub for mRNA, DNA and recombinant vaccines. Supachai